Safety and Clinical Activity of PD-L1 Blockade in Patients With Aggressive Recurrent Respiratory Papillomatosis

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/s40425-019-0603-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Recurrent Respiratory Papillomatosis

2020English

Recurrent Respiratory Papillomatosis

Radiographics
MedicineNuclear MedicineRadiologyImaging
2018English

Clinical Course of Recurrent Respiratory Papillomatosis in Danish Children

Archives of Otolaryngology–Head & Neck Surgery
2004English

83 Recurrent Respiratory Papillomatosis

2018English

Clinical Activity of Nivolumab for Human Papilloma Virus‐Related Juvenile‐Onset Recurrent Respiratory Papillomatosis

Oncologist
Cancer ResearchMedicineOncology
2019English

Recurrent Respiratory Papillomatosis: Review and Treatment Update

Journal of Otolaryngology and Rhinology
2018English

Recurrent Respiratory Papillomatosis (RRP)—Juvenile Onset

Clinical medicine. Oncology
2008English

Voice Improvement in Patients With Recurrent Respiratory Papillomatosis After Combined Treatment With Cidofovir and CO2 Laser Surgery

Lasers in Medical Science
DermatologySurgery
2019English

Oncolytic Virus and PD-1/PD-L1 Blockade Combination Therapy

Oncolytic Virotherapy
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy